DigiDiab Evaluation Domiciliary Nursing Care

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 15, 2025

Conditions
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 Diabetes, Insulin Requiring
Interventions
DEVICE

GlucoTab

Insulin therapy will be started and adjusted according to the GlucoTab system with incorporated software algorithm. The goal of the basal insulin algorithm is to maintain blood glucose (BG) within acceptable targets according to the predefined health status. For a limited time period after therapy start, three BG measurements per day are suggested by the algorithm to determine blood glucose. Insulin dosage titration will be performed according to the algorithm in GlucoTab under supervision of the nurses of domiciliary nursing care. Correctional bolus insulin will be administered at defined time-points according to BG targets in the predefined health status. Nurses and nursing assistants will be trained in the use of the GlucoTab system.

OTHER

Diabetes Treatment

Diabetes Standard Care

Trial Locations (1)

Unknown

Austrian Red Cross, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT06616779 - DigiDiab Evaluation Domiciliary Nursing Care | Biotech Hunter | Biotech Hunter